4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity

BCSCP Board Certified Sterile Compounding Pharmacist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, USP Standards & CSP Categories

1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions

2 Chapter 2: Facilities, Engineering Controls & Cleaning

2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures

3 Chapter 3: Environmental Monitoring & Facility Certification

3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols

4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique

4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity

5 Chapter 5: Beyond-Use Dating, Storage & Container Rules

5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules

6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding

6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)

7 Chapter 7: Materials, Equipment & Compounding Workflow

7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs

8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility

8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics

9 Chapter 9: Therapeutics, Administration & Patient Monitoring

9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations

10 Chapter 10: Quality Management, Records & Personnel Competency

10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence

11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain

11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA

12 Chapter 12: Safety Management, Investigations, Recalls & Waste

12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management

4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity

Key Takeaways Explain This Topic AI

The Direct Compounding Area (DCA) is the critical space within the ISO Class 5 PEC where materials are manipulated and critical sites are exposed to unobstructed 'First Air'.

Critical sites (vial rubber septa, open ampule necks, syringe tips/plungers, needle hubs, transfer ports) must never be touched or blocked from first air.

Critical sites must be disinfected by wiping with sterile 70% IPA using a sterile wipe in a single direction with firm pressure, allowing the IPA to dry completely before puncture.

Glass ampules must be broken away from the HEPA filter and operator at a 45-degree angle; a 5-micron filter needle or straw must be used for liquid withdrawal and replaced with a regular needle before injection.

Needle entry into vial septa must be executed at a 45-degree angle with the bevel facing up, transitioning to 90 degrees to prevent coring of the rubber stopper.

Last updated: September 2026

The Direct Compounding Area (DCA) and Critical Sites

The Direct Compounding Area (DCA) is the specific zone within an ISO Class 5 primary engineering control where aseptic manipulations occur and where sterile components are exposed to the environment. The primary objective of aseptic technique is the absolute preservation of critical sites from microbial and physical contamination.

Identification of Critical Sites

A critical site is any surface, opening, or pathway through which fluid or air enters or exits a sterile system:

Vial Rubber Septa : The central puncture target on commercial vials.

Ampule Necks : The scored glass fracture point.

Syringe Plungers and Tips : The Luer-lock tip and the inner ribbed shaft of the syringe plunger.

Needle Hubs and Shafts : The plastic hub connecting to the syringe and the entire metal needle lumen.

IV Bag Spike Ports and Additive Injection Ports : The rubber membrane port where transfer spikes and needles enter.

Important

Personnel must never touch a critical site with their gloved hands, even if gloves have been sanitized with sterile 70% IPA. Sterile gloves are not infallible—touch contamination remains the leading cause of compounding contamination.

First Air Integrity and Shadowing Prevention

First Air is the unidirectional, HEPA-filtered air that exits the filter face and reaches critical sites before encountering any obstruction. When First Air strikes an object (such as a vial, automated pump, or worker's hand), it creates a downstream turbulent wake or "dead zone" known as airflow shadowing .

Airflow Positioning Rules

In a Horizontal LAFW (airflow moving from back to front):

First Air flows horizontally toward the operator.

Hands and objects must never be positioned between the HEPA filter (rear) and the critical site .

Large objects must be placed toward the sides of the work deck to avoid blocking horizontal streamlines.

In a Vertical Flow Hood (BSC or Vertical LAFW) (airflow moving from ceiling down to deck):

First Air flows downward from above.

Hands and objects must never be positioned directly above critical sites .

Manipulations must be performed with hands approaching from the side.

Distance Rules : Standard aseptic training has manipulations done at least 6 inches inside the front edge of the PEC, with items kept clear of the side walls and the filter face. USP does not set these distances. They follow from where airflow is steady.

Critical Site Disinfection & Coring Prevention
Disinfection of Vial Rubber Septa

Commercial vial flip-top caps are dust covers, not sterile seals. Vial septa must be disinfected:

Agent : Use sterile 70% Isopropyl Alcohol (IPA) applied with a low-lint sterile wipe.

Technique : Wipe the septum in a single direction with firm friction (scrubbing back and forth re-deposits particles).

Evaporation Requirement : USP <797> requires the sterile 70% IPA to dry completely before the stopper is punctured. Inserting a needle through wet alcohol forces liquid alcohol into the medication vial, causing chemical degradation and protein denaturation, and compromises the seal.

Prevention of Rubber Septum Coring

Coring occurs when the needle cutting edge shears off a cylindrical plug of rubber, introducing a particulate contaminant into the solution:

Position the needle at a 45-degree angle to the rubber stopper with the bevel facing upward .

Apply forward pressure while simultaneously rotating the needle upward to a 90-degree angle as the heel enters the stopper.

This cuts a clean flap of rubber rather than carving out a core plug. Needle Bevel UP (45° Angle)
\ ◄── Bevel Facing Upward
\
═══════\══════════════ [Vial Rubber Stopper]
\ ──► Rotate to 90° as heel enters
Glass Ampule Handling

Glass ampules present severe risks of glass particulate contamination:

Tap the ampule head to dislodge fluid from the top.

Swab the neck with sterile 70% IPA and allow to dry.

Wrap a sterile alcohol swab or gauze around the neck and snap the ampule away from the HEPA filter and operator at a 45-degree angle.

Mandatory Filtration : Fluid withdrawn from an ampule must be passed through a 5-micron filter (filter needle or filter straw) to remove microscopic glass shards.

One-Way Rule : A filter needle must be used in one direction only . If used to draw fluid out of the ampule, it must be removed and replaced with a standard needle before injecting the medication into an IV bag; injecting through the same filter needle pushes captured glass particles directly into the patient's infusion.

Syringe Volumetric Accuracy & Plunger Mechanics

Accurate dosing in sterile compounding relies on proper syringe selection and manipulation:

Volumetric Graduation Alignment : Liquid volume must be read at the final leading contact ring of the rubber plunger piston aligned precisely with the barrel graduation mark. Reading from the dome tip, cone, or rear ring introduces severe volumetric error.

Syringe Capacity Selection Rule : Choose the smallest syringe that holds the intended volume. A small volume measured in a large syringe carries a large relative error, because each graduation represents a bigger share of the dose. For example, 0.2 mL 0.2\,\text{mL} 0.2 mL belongs in a 1 mL 1\,\text{mL} 1 mL syringe, not a 10 mL 10\,\text{mL} 10 mL syringe.

Plunger Rib Contamination : The inner ribbed shaft of the syringe plunger enters the internal barrel during injection. Operators must manipulate the syringe exclusively by the barrel and plunger flange; touching the ribbed plunger shaft introduces microbes and skin squames that are swept directly into the sterile drug path upon fluid expulsion.

USP <797> Rules for Items Entering the PEC

Just before any item enters the PEC, wipe it with sterile 70% IPA on a sterile low-lint wiper and let it dry. Sterile supplies in sealed sterile packaging may instead be removed from the wrapper as they enter the ISO Class 5 space.

Wiping must not make the product label unreadable.

Critical sites (vial stoppers, ampule necks, IV bag septums) are wiped with sterile 70% IPA in the PEC and allowed to dry before they are punctured or opened.

Only equipment needed for the task goes into the PEC. Its placement must first be checked with a dynamic airflow smoke pattern test, which is repeated if the equipment is moved.

Sterile 70% IPA goes on the gloves immediately before compounding and regularly during it. Gloves are inspected and replaced at once if torn or punctured.